[CUV] QoQ Quarter Result on 30-Jun-2024 [#Q4]

Stock
[CUV] Clinuvel Pharmaceuticals Limited
Announcement Date
28-Jun-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q4]
Profit Trend
QoQ- 125.86%
YoY- 28.53%
Quarter Report
CUV's Result
CUV's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
Revenue 55,376 32,257 48,966 29,355 41,091 24,631 32,232 19.74%
PBT 35,873 14,806 30,979 14,600 25,595 8,726 19,902 21.67%
Tax 11,173 3,870 11,762 3,212 10,587 2,855 1,661 88.66%
NP 24,700 10,936 19,217 11,388 15,008 5,870 18,241 10.62%
Tax Rate -31.15% -26.14% -37.97% -22.00% -41.36% -32.72% -8.35% -
Total Cost 30,676 21,321 29,749 17,967 26,083 18,761 13,991 29.88%
Ratio Analysis
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
NP Margin 44.60 33.90 39.25 38.79 36.52 23.83 56.59 -7.62%
Per Share
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
EPS 0.49 0.22 0.39 0.23 0.30 0.12 0.37 9.80%
EPS Diluted 0.49 0.21 0.37 0.22 0.29 0.11 0.36 10.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.